Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
KsyuzHd6XZWM4Jjp
